RCC Laboratories, a leading CRO providing preclinical and safety toxicology and chemical testing globally and ViruSure GmbH have entered into an alliance to market the services of ViruSure in India.
Through this partnership RCC will act as a sole agent for promoting ViruSure services in India. The company offers services in the areas of virus and prion safety testing for biopharmaceutical products, cell banking and cell bank characterization services and in vivo biosafety studies (adventitious agent testing, tumourigenicity testing, oncogenicity testing), which are highly valuable to pharma and biotech companies specializing on biological products (e.g. recombinant proteins, vaccines, human and animal derived biological products, cell based therapies).
“We are happy to partner with such a renowned company as RCC, who shares the same philosophy of quality and customer service that has made ViruSure successful,” stated Andy Bailey, CEO and co-founder, ViruSure.
“We look forward to offer our experience to assist Indian biopharmaceutical companies in reaching their goals for pathogen safety testing”. The partnership is a natural fit, since both RCC and ViruSure will help Indian companies elevate their quality standards through their combined service offerings, he added.
RCC offers OECD toxicology services to various companies in India and globally, with quality, and transparency as the main focus. With an experienced team of toxicologists, RCC is a leader in pre-clinical toxicology services in Asia. The company specialises in breeding and toxicology, genetic toxicology, environmental toxicology, analytical chemistry, pathology for wide variety of industries such as pharmaceutical, biotechnology, agrochemical, industrial chemical, medical device, cosmetic and food processing with certification from OECD, Indian and Swizz GLP. It has a global clientele in 50 countries, and has experience in submitting reports to more than 80 countries.
ViruSure is a privately owned biotech company specializing in the virus and prion safety testing of biopharmaceutical products and cell bankincharacterization services with a world wide client base. The company brings a wealth of expertise to ensure that biopharmaceutical companies meet all relevant pathogen safety testing requirements.